ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.60044
-0.13%
Brent Oil
82.125
-0.39%
Bitcoin
69,944.01
-0.27%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Neurobiological Technologies (MM) (NTII)

  7. Neurobiological Technologies (MM) (NTII) Noticias

NTII

Neurobiological (NTII)

Neurobiological Technologies (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NTII
FechaHoraFuenteTítuloSímboloCompañía
07/12/200913:18Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
07/12/200912:41Edgar (US Regulatory)-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)NASDAQ:NTIINeurobiological Technologies (MM)
23/11/200907:00PR Newswire (US)Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per ShareNASDAQ:NTII
16/11/200912:43Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NTIINeurobiological Technologies (MM)
09/11/200915:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
28/10/200908:00PR Newswire (US)Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and DissolutionNASDAQ:NTII
26/10/200913:00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTIINeurobiological Technologies (MM)
26/10/200912:59Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:NTIINeurobiological Technologies (MM)
23/10/200916:19Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:NTIINeurobiological Technologies (MM)
19/10/200915:20PR Newswire (US)Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital MarketNASDAQ:NTII
22/09/200905:01Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NTIINeurobiological Technologies (MM)
17/09/200916:00PR Newswire (US)Neurobiological Technologies Receives Nasdaq Closing Bid Price NotificationNASDAQ:NTII
08/09/200915:28Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NTIINeurobiological Technologies (MM)
31/08/200915:27PR Newswire (US)Neurobiological Technologies Announces Board Approval of Plan of Liquidation and DissolutionNASDAQ:NTIINeurobiological Technologies (MM)
31/08/200915:14Edgar (US Regulatory)Annual Report (10-K)NASDAQ:NTIINeurobiological Technologies (MM)
12/08/200907:30PR Newswire (US)Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Children's Medical CenNASDAQ:NTIINeurobiological Technologies (MM)
01/06/200907:30PR Newswire (US)Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical ProgramNASDAQ:NTIINeurobiological Technologies (MM)
08/05/200906:00PR Newswire (US)Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
01/05/200906:00PR Newswire (US)Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of MemantineNASDAQ:NTIINeurobiological Technologies (MM)
26/03/200906:30PR Newswire (US)Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of CompanyNASDAQ:NTIINeurobiological Technologies (MM)
18/02/200905:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:NTIINeurobiological Technologies (MM)
12/02/200915:30PR Newswire (US)Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
05/02/200915:17Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:NTIINeurobiological Technologies (MM)
04/02/200906:00PR Newswire (US)Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEONASDAQ:NTIINeurobiological Technologies (MM)
23/01/200905:02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:NTIINeurobiological Technologies (MM)
13/01/200906:30PR Newswire (US)Neurobiological Technologies Announces Suspension of Viprinex DevelopmentNASDAQ:NTIINeurobiological Technologies (MM)
17/12/200806:00PR Newswire (US)Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility AnalysisNASDAQ:NTIINeurobiological Technologies (MM)
16/12/200807:00PR Newswire (US)Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009NASDAQ:NTIINeurobiological Technologies (MM)
06/11/200805:30PR Newswire (US)Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
05/11/200815:08Edgar (US Regulatory)Amended Securities Registration (section 12(g)) (8-A12G/A)NASDAQ:NTIINeurobiological Technologies (MM)
 Showing the most relevant articles for your search:NASDAQ:NTII

Su Consulta Reciente

NYSE
MCD
McDonalds
NYSE
VZ
Verizon Communications
COIN
SOLUSD
Solana
COIN
BTCUSD
Bitcoin
FX
EURMXN
Euro vs MXN
USOTC
BASFY
BASF (QX)
NYSE
BAC
Bank of America
SPI
SP500
S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
DIS
Walt Disney
CCOM
OILBRENT
Brent Oil
CCOM
US500
US 500
NYSE
CVX
Chevron
NYSE
MRK
Merck
NYSE
KO
Coca Cola
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados